Gastrointestinal Endoscopy
Volume 60, Issue 5 , Pages 714-720 , November 2004

The characteristics and the prognosis for patients presenting with actively bleeding esophageal varices at endoscopy

Received 24 May 2004 ,Revised 8 July 2004 ,Accepted 26 July 2004.

References 

  1. Terblanche J, Burroughs AK, Hobbs KEF. Controversies in the management of bleeding esophageal varices. N Engl J Med. 1989;320:1393–1398
  2. Infante-Rivard C, Esnaola S, Villeneuve JP. Role of endoscopic variceal sclerotherapy in the long-term management of variceal bleeding: a meta-analysis. Gastroenterology. 1989;96:1087–1092
  3. Lo GH, Lai KH, Ng WW, Tam TN, Lee SD, Tsai YT, et al. Injection sclerotherapy preceded by esophageal tamponade versus immediate sclerotherapy in arresting active variceal bleeding: a prospective randomized trial. Gastrointest Endosc. 1992;38:421–424
  4. Laine L, Cook D. Endoscopic ligation compared with sclerotherapy for treatment of esophageal variceal bleeding. A meta-analysis. Ann Intern Med. 1995;123:280–287
  5. Lo GH, Lai KH, Cheng JS, Hwu JH, Chang CF, Chen SM, et al. A prospective, randomized trial of sclerotherapy versus ligation in the management of bleeding esophageal varices. Hepatology. 1995;22:466–471
  6. Ben-Ari Z, Cardin F, McCormick AP, Wannamethee G, Burroughs AK. A predictive model for failure to control bleeding during acute variceal hemorrhage. J Hepatol. 1999;31:443–450
  7. De Franchis R. Updating consensus in portal hypertension: report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension. J Hepatol. 2000;33:846–852
  8. Lo GH, Lai KH, Cheng JS, Lin CK, Huang JS, Hsu PI, et al. Emergency banding ligation versus sclerotherapy for the control of active bleeding from esophageal varices. Hepatology. 1997;25:1101–1104
  9. Lo GH, Lai KH, Cheng JS, Chen MM, Huang HC, Hsu PI, et al. Endoscopic variceal ligation plus nadolol and sucralfate compared with ligation alone for the prevention of variceal rebleeding: a prospective, randomized trial. Hepatology. 2000;32:461–465
  10. Lo GH, Chen WC, Chen MH, Hsu PI, Lin CK, Tsai WL, et al. A prospective, randomized trial of endoscopic variceal ligation versus nadolol and isosorbide mononitrate for the prevention of esophageal variceal rebleeding. Gastroenterology. 2002;123:728–734
  11. Burroughs AK, Alexandrino P, Cales P, Fleig W, Grace N, Minoli G, et al. Sore points. In:  de Franchis R editors. Portal hypertension II. Proceedings of the second Baveno international consensus workshop on definitions, methodology and therapeutic strategies. Oxford: Blackwell Science; 1996;p. 10–17
  12. Pugh RNN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of esophagus for bleeding esophageal varices. Br J Surg. 1973;60:646–649
  13. Beppu K, Inokuchi K, Koyanagi N, Nakayama S, Sakata H, Kitano B, et al. Prediction of variceal hemorrhage by esophageal endoscopy. Gastrointest Endosc. 1981;27:213–218
  14. Sarin SK, Govil A, Jain AK, Guptan RC, Issar SK, Jain M, et al. Prospective randomized trial of endoscopic sclerotherapy versus variceal band ligation for esophageal varices: influence on gastropathy, gastric varices and variceal recurrence. J Hepatol. 1997;26:826–832
  15. The Copenhagen Esophageal Variceal Sclerotherapy Project. Sclerotherapy after first variceal hemorrhage in cirrhosis: a randomized multicenter trial. N Engl J Med. 1984;311:1594–1600
  16. Laine L. Ligation: endoscopic treatment of choice for patients with bleeding esophageal varices?. [editorial] Hepatology. 1995;22:663–665
  17. Hartigan PM, Gebhard RL, Gregory PB. Sclerotherapy for actively bleeding esophageal varices in male alcoholics with cirrhosis. Gastrointest Endosc. 1997;46:1–7
  18. Hou MC, Lin HC, Kuo BIT, Lee FY, Schmidt CM, Lee SD. Clinical implications of the white nipple sign and its role in the diagnosis of esophageal variceal hemorrhage. Am J Gastroenterol. 1996;91:2103–2109
  19. Cales P, Masliah C, Bernard B, Garnier PP, Silvain C, Szostak-Talbodec N, et al. Early administration of vapreotide for variceal bleeding in patients with cirrhosis. N Engl J Med. 2001;344:23–28
  20. D'Amico G, Politi F, Morabito A, D'Antoni A, Guerrera D, Giannuoli G, et al. Octreotide compared with placebo in a treatment strategy for early rebleeding in cirrhosis. A double-blind, randomized pragmatic trial. Hepatology. 1998;28:1206–1214
  21. Kleber G, Sauerbruch T, Ansari H, Paumgartner G. Prediction of variceal hemorrhage in cirrhosis: a prospective follow-up study. Gastroenterology. 1991;100:1332–1337
  22. Stiegmann GV, Goff JS, Sun JH, Wilborn S. Endoscopic elastic band ligation for active variceal hemorrhage. Am Surg. 1989;55:124–128
  23. Banares R, Albillos A, Rincon D, Alonso S, Gonzalez M, Ruiz-del-Arbol L, et al. Endoscopic treatment versus endoscopic plus pharmacologic treatment for acute variceal bleeding: A meta-analysis. Hepatology. 2002;35:609–615
  24. Balanzo J, Villanueva C, Espinos J. Predictive value of the endoscopic signs in variceal bleeding. [abstract] J Hepatol. 1991;13(Suppl 2):S93
  25. Chalasani N, Kahi C, Francois F, Pinto A, Marathe A, Bini EJ, et al. Improved patient survival after acute variceal bleeding: a multicenter, cohort study. Am J Gastroenterol. 2003;98:653–659

PII: S0016-5107(04)02050-4

Gastrointestinal Endoscopy
Volume 60, Issue 5 , Pages 714-720 , November 2004

Article Tools

* Image Usage & Resolution